293 related articles for article (PubMed ID: 22706088)
21. Tim3
Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
[TBL] [Abstract][Full Text] [Related]
22. Tim-1 stimulation of dendritic cells regulates the balance between effector and regulatory T cells.
Xiao S; Zhu B; Jin H; Zhu C; Umetsu DT; DeKruyff RH; Kuchroo VK
Eur J Immunol; 2011 Jun; 41(6):1539-49. PubMed ID: 21469101
[TBL] [Abstract][Full Text] [Related]
23. Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection.
Abel S; Lückheide N; Westendorf AM; Geffers R; Roers A; Müller W; Sparwasser T; Matuschewski K; Buer J; Hansen W
J Immunol; 2012 Jun; 188(11):5467-77. PubMed ID: 22544931
[TBL] [Abstract][Full Text] [Related]
24. Neem leaf glycoprotein inhibits CD4+CD25+Foxp3+ Tregs to restrict murine tumor growth.
Chakraborty T; Bose A; Barik S; Goswami KK; Banerjee S; Goswami S; Ghosh D; Roy S; Chakraborty K; Sarkar K; Baral R
Immunotherapy; 2011 Aug; 3(8):949-69. PubMed ID: 21843083
[TBL] [Abstract][Full Text] [Related]
25. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells.
Chen X; Bäumel M; Männel DN; Howard OM; Oppenheim JJ
J Immunol; 2007 Jul; 179(1):154-61. PubMed ID: 17579033
[TBL] [Abstract][Full Text] [Related]
26. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
27. Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.
Hu G; Liu Z; Zheng C; Zheng SG
Cell Mol Immunol; 2010 Nov; 7(6):414-8. PubMed ID: 20729905
[TBL] [Abstract][Full Text] [Related]
28. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
[TBL] [Abstract][Full Text] [Related]
29. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
31. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
[TBL] [Abstract][Full Text] [Related]
32. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
[TBL] [Abstract][Full Text] [Related]
33. Analysis of FOXP3+ regulatory T cells that display apparent viral antigen specificity during chronic hepatitis C virus infection.
Li S; Floess S; Hamann A; Gaudieri S; Lucas A; Hellard M; Roberts S; Paukovic G; Plebanski M; Loveland BE; Aitken C; Barry S; Schofield L; Gowans EJ
PLoS Pathog; 2009 Dec; 5(12):e1000707. PubMed ID: 20041222
[TBL] [Abstract][Full Text] [Related]
34. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
35. Circulating CD4(+) CD25(high) FoxP3(+) T-regulatory cells in patients with atopic dermatitis after narrowband-ultraviolet B phototherapy.
El Samahy MH; Attia EA; Saad AA; Mahmoud EY
Int J Dermatol; 2015 Oct; 54(10):e424-9. PubMed ID: 26219909
[TBL] [Abstract][Full Text] [Related]
36. CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.
Baecher-Allan CM; Costantino CM; Cvetanovich GL; Ashley CW; Beriou G; Dominguez-Villar M; Hafler DA
J Immunol; 2011 Mar; 186(6):3317-26. PubMed ID: 21300823
[TBL] [Abstract][Full Text] [Related]
37. Expansion of CD4+ CD25+ FoxP3+ regulatory T cells in chronic hepatitis C virus infection.
Hashempoor T; Bamdad T; Merat S; Janzamin E; Nemati L; Jabbari H; Sharifi AH; Zamini H
Iran J Immunol; 2010 Sep; 7(3):177-85. PubMed ID: 20876988
[TBL] [Abstract][Full Text] [Related]
38. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis.
Bending D; Pesenacker AM; Ursu S; Wu Q; Lom H; Thirugnanabalan B; Wedderburn LR
J Immunol; 2014 Sep; 193(6):2699-708. PubMed ID: 25092890
[TBL] [Abstract][Full Text] [Related]
39. Effects of interleukin 4 on CD25+CD4+ regulatory T cell function.
Maerten P; Shen C; Bullens DM; Van Assche G; Van Gool S; Geboes K; Rutgeerts P; Ceuppens JL
J Autoimmun; 2005 Sep; 25(2):112-20. PubMed ID: 16051465
[TBL] [Abstract][Full Text] [Related]
40. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
McMahan RH; Golden-Mason L; Nishimura MI; McMahon BJ; Kemper M; Allen TM; Gretch DR; Rosen HR
J Clin Invest; 2010 Dec; 120(12):4546-57. PubMed ID: 21084749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
